360 related articles for article (PubMed ID: 8106152)
1. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel.
Cortes JE; Pazdur R
J Clin Oncol; 1995 Oct; 13(10):2643-55. PubMed ID: 7595719
[TBL] [Abstract][Full Text] [Related]
3. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.
Pronk LC; Stoter G; Verweij J
Cancer Treat Rev; 1995 Sep; 21(5):463-78. PubMed ID: 8556719
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
Verweij J; Clavel M; Chevalier B
Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
[TBL] [Abstract][Full Text] [Related]
7. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
9. The taxoids: paclitaxel and docetaxel.
Gelmon K
Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
[No Abstract] [Full Text] [Related]
10. The taxoids. Comparative clinical pharmacology and therapeutic potential.
Eisenhauer EA; Vermorken JB
Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
[TBL] [Abstract][Full Text] [Related]
11. Taxol in ovarian cancer.
Runowicz CD; Wiernik PH; Einzig AI; Goldberg GL; Horwitz SB
Cancer; 1993 Feb; 71(4 Suppl):1591-6. PubMed ID: 8094322
[TBL] [Abstract][Full Text] [Related]
12. The international experience with docetaxel in the treatment of breast cancer.
Ravdin PM
Oncology (Williston Park); 1997 Mar; 11(3 Suppl 2):38-42. PubMed ID: 9110341
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel (Taxotere) in combination: a step forward.
Burris HA; Fields S; Peacock N
Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452
[TBL] [Abstract][Full Text] [Related]
14. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
[TBL] [Abstract][Full Text] [Related]
15. Taxoids in combination chemotherapy for metastatic breast cancer.
Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
[TBL] [Abstract][Full Text] [Related]
16. Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview.
Kaye SB; Piccart M; Aapro M; Francis P; Kavanagh J
Eur J Cancer; 1997 Nov; 33(13):2167-70. PubMed ID: 9470802
[TBL] [Abstract][Full Text] [Related]
17. Taxoids: a new class of cytotoxic agents.
Marty M; Extra JM; Giacchetti S; Cuvier C; Espie M
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S25-8. PubMed ID: 7909941
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer.
Piccart MJ; Gore M; Ten Bokkel Huinink W; Van Oosterom A; Verweij J; Wanders J; Franklin H; Bayssas M; Kaye S
J Natl Cancer Inst; 1995 May; 87(9):676-81. PubMed ID: 7752272
[TBL] [Abstract][Full Text] [Related]
19. [Taxotere as second-line for metastatic breast cancer].
Culine S
Rev Med Interne; 1999 Mar; 20(3):277-80. PubMed ID: 10216887
[TBL] [Abstract][Full Text] [Related]
20. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer.
Hassett G; Harnett P; Manolios N
Clin Exp Rheumatol; 2001; 19(2):197-200. PubMed ID: 11326485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
